Top

Published in:

01-09-2016 | Original Article

Breast cancer survivors suffer from persistent postmastectomy pain syndrome and posttraumatic stress disorder (ORTHUS study): a study of the palliative care working committee of the Turkish Oncology Group (TOG)

Authors: Ali Alkan, Zeynep Gulsum Guc, Filiz Cay Senler, Tugba Yavuzsen, Handan Onur, Mutlu Dogan, Ebru Karci, Arzu Yasar, Elif Berna Koksoy, Ozgur Tanriverdi, Serdar Turhal, Yuksel Urun, Asiye Ozkan, Dilsa Mizrak, Hakan Akbulut

Published in: Supportive Care in Cancer | Issue 9/2016

Abstract

Purpose

Persistent postmastectomy pain syndrome (PMPS) is one of the most important disturbing symptoms. Posttraumatic stress disorder (PTSD) is an anxiety disorder which is characterized by reactions to reminders of the trauma that has been experienced. The purpose of this study is to evaluate the predictors of PMPS and PTSD in Turkish breast cancer survivors and the correlation between PMPS and PTSD.

Method

The study is designed as a multicenter survey study. Breast cancer patients in remission were evaluated. Patients were evaluated with structured questionnaires to assess the PMPS and clinical parameters associated with it. The Turkish version of the posttraumatic stress disorder checklist—civilian version (PCL-C) was used.

Results

Between February 2015 and October 2015, 614 breast cancer survivors in outpatient clinics were evaluated. The incidence of PMPS documented is 45.1 %. In the multivariate analysis low income, presence of PTSD and <46 months after surgery were associated with increased risk of PMPS. PTSD was documented in 75 %, and the mean PCL-C score was 32.4 ± 11.1. PMPS and being married at the time of the evaluation were linked with PTSD.

Conclusions

It is the first data about the association between PMPS and PTSD. The clinicians should be aware of PMPS and PTSD in breast cancer survivors.

Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ et al (2011) Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 378(9801):1461–1484CrossRefPubMed

Foley KM (1987) Pain syndromes in patients with cancer. Med Clin North Am 71(2):169–184CrossRefPubMed

Carpenter JS, Andrykowski MA, Sloan P, Cunningham L, Cordova MJ, Studts JL et al (1998) Postmastectomy/postlumpectomy pain in breast cancer survivors. J Clin Epidemiol 51(12):1285–1292CrossRefPubMed

Stevens PE, Dibble SL, Miaskowski C (1995) Prevalence, characteristics, and impact of postmastectomy pain syndrome: an investigation of women’s experiences. Pain 61(1):61–68CrossRefPubMed

Jung BF, Ahrendt GM, Oaklander AL, Dworkin RH (2003) Neuropathic pain following breast cancer surgery: proposed classification and research update. Pain 104(1-2):1–13CrossRefPubMed

Gartner R, Jensen MB, Nielsen J, Ewertz M, Kroman N, Kehlet H (2009) Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA 302(18):1985–1992CrossRefPubMed

Smith WC, Bourne D, Squair J, Phillips DO, Chambers WA (1999) A retrospective cohort study of post mastectomy pain syndrome. Pain 83(1):91–95CrossRefPubMed

Macdonald L, Bruce J, Scott NW, Smith WC, Chambers WA (2005) Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome. Br J Cancer 92(2):225–230PubMedPubMedCentral

Vilholm OJ, Cold S, Rasmussen L, Sindrup SH (2008) The postmastectomy pain syndrome: an epidemiological study on the prevalence of chronic pain after surgery for breast cancer. Br J Cancer 99(4):604–610CrossRefPubMedPubMedCentral

10.

Caffo O, Amichetti M, Ferro A, Lucenti A, Valduga F, Galligioni E (2003) Pain and quality of life after surgery for breast cancer. Breast Cancer Res Treat 80(1):39–48CrossRefPubMed

11.

Finnerup NB, Sindrup SH, Jensen TS (2007) Chronic neuropathic pain: mechanisms, drug targets and measurement. Fundam Clin Pharmacol 21(2):129–136CrossRefPubMed

12.

Watson CP, Evans RJ (1992) The postmastectomy pain syndrome and topical capsaicin: a randomized trial. Pain 51(3):375–379CrossRefPubMed

13.

Wisotzky EM, Saini V, Kao C. Ultrasound guided intercostobrachial peri-neural injection for intercostobrachial neuralgia in breast cancer patients: a case series. PM & R: the journal of injury, function, and rehabilitation. 2015.

14.

Amr YM, Yousef AA (2010) Evaluation of efficacy of the perioperative administration of venlafaxine or gabapentin on acute and chronic postmastectomy pain. Clin J Pain 26(5):381–385CrossRefPubMed

15.

Eisenberg E, Pud D, Koltun L, Loven D (2007) Effect of early administration of the N-methyl-d-aspartate receptor antagonist amantadine on the development of postmastectomy pain syndrome: a prospective pilot study. J Pain 8(3):223–229CrossRefPubMed

16.

Vilholm OJ, Cold S, Rasmussen L, Sindrup SH (2008) Effect of levetiracetam on the postmastectomy pain syndrome. Eur J Neurol 15(8):851–857CrossRefPubMed

17.

Hahn EE, Hays RD, Kahn KL, Litwin MS, Ganz PA (2015) Post-traumatic stress symptoms in cancer survivors: relationship to the impact of cancer scale and other associated risk factors. Psychooncology 24(6):643–652CrossRefPubMed

18.

Ljungman L, Hoven E, Ljungman G, Cernvall M, von Essen L (2015) Does time heal all wounds? A longitudinal study of the development of posttraumatic stress symptoms in parents of survivors of childhood cancer and bereaved parents. Psychooncology 24(12):1792–1798CrossRefPubMed

19.

Wachen JS, Patidar SM, Mulligan EA, Naik AD, Moye J (2014) Cancer-related PTSD symptoms in a veteran sample: association with age, combat PTSD, and quality of life. Psychooncology 23(8):921–927CrossRefPubMedPubMedCentral

20.

Tremolada M, Bonichini S, Aloisio D, Schiavo S, Carli M, Pillon M (2013) Post-traumatic stress symptoms among mothers of children with leukemia undergoing treatment: a longitudinal study. Psychooncology 22(6):1266–1272CrossRefPubMed

21.

Alter CL, Pelcovitz D, Axelrod A, Goldenberg B, Harris H, Meyers B et al (1996) Identification of PTSD in cancer survivors. Psychosomatics 37(2):137–143CrossRefPubMed

22.

Mundy EA, Blanchard EB, Cirenza E, Gargiulo J, Maloy B, Blanchard CG (2000) Posttraumatic stress disorder in breast cancer patients following autologous bone marrow transplantation or conventional cancer treatments. Behav Res Ther 38(10):1015–1027CrossRefPubMed

23.

Kangas M, Henry JL, Bryant RA (2002) Posttraumatic stress disorder following cancer. A conceptual and empirical review. Clin Psychol Rev 22(4):499–524CrossRefPubMed

24.

Rustad JK, David D, Currier MB (2012) Cancer and post-traumatic stress disorder: diagnosis, pathogenesis and treatment considerations. Palliat Support Care 10(3):213CrossRefPubMed

25.

Andrykowski MA, Cordova MJ, McGrath PC, Sloan DA, Kenady DE (2000) Stability and change in posttraumatic stress disorder symptoms following breast cancer treatment: a 1-year follow-up. Psychooncology 9(1):69–78CrossRefPubMed

26.

Dobie DJ, Kivlahan DR, Maynard C, Bush KR, McFall M, Epler AJ et al (2002) Screening for post-traumatic stress disorder in female Veteran’s Affairs patients: validation of the PTSD checklist. Gen Hosp Psychiatry 24(6):367–374CrossRefPubMed

27.

Kocabaşoğlu NÇÖA, Yargıç İ, Geyran P (2005) Türkçe “PTSD checklist—civilian version” (PCL-C) ölçeğinin geçerlilik ve güvenilirliği. Yeni Symposium 43(3):126–134

28.

Semiz MEF, Erdem A, Tuman TC, Oran Demir M, Kayka N, Yıldırım O (2015) Posttraumatic stress disorder symptoms in patients with acute myocardial infarction. Abant Med J 4(1):47–53CrossRef

29.

Balaban H, Semiz M, Senturk IA, Kavakci O, Cinar Z, Dikici A et al (2012) Migraine prevalence, alexithymia, and post-traumatic stress disorder among medical students in Turkey. J Headache Pain 13(6):459–467CrossRefPubMedPubMedCentral

30.

Meijuan Y, Zhiyou P, Yuwen T, Ying F, Xinzhong C (2013) A retrospective study of postmastectomy pain syndrome: incidence, characteristics, risk factors, and influence on quality of life. Sci World J 2013:159732CrossRef

31.

Couceiro TC, Menezes TC, Valenca MM (2009) Post-mastectomy pain syndrome: the magnitude of the problem. Rev Bras Anestesiol 59(3):358–365CrossRefPubMed

32.

Tasmuth T, von Smitten K, Kalso E (1996) Pain and other symptoms during the first year after radical and conservative surgery for breast cancer. Br J Cancer 74(12):2024–2031CrossRefPubMedPubMedCentral

33.

Katz J, Poleshuck EL, Andrus CH, Hogan LA, Jung BF, Kulick DI et al (2005) Risk factors for acute pain and its persistence following breast cancer surgery. Pain 119(1-3):16–25CrossRefPubMed

34.

Poleshuck EL, Katz J, Andrus CH, Hogan LA, Jung BF, Kulick DI et al (2006) Risk factors for chronic pain following breast cancer surgery: a prospective study. J Pain 7(9):626–634CrossRefPubMed

35.

Altinel L, Kose KC, Ergan V, Isik C, Aksoy Y, Ozdemir A et al (2008) The prevalence of low back pain and risk factors among adult population in Afyon region, Turkey. Acta Orthop Traumatol Turc 42(5):328–333CrossRefPubMed

36.

Pina P, Sabri E, Lawlor PG (2015) Characteristics and associations of pain intensity in patients referred to a specialist cancer pain clinic. Pain Res Manag 20(5):249–254CrossRefPubMedPubMedCentral

37.

Dunne-Proctor RL, Kenardy J, Sterling M. The impact of posttraumatic stress disorder on physiological arousal, disability and sensory pain thresholds in patients with chronic whiplash. Clin J Pain, 2015

38.

Wallace MS, Wallace AM, Lee J, Dobke MK (1996) Pain after breast surgery: a survey of 282 women. Pain 66(2-3):195–205CrossRefPubMed

39.

Tasmuth T, Kataja M, Blomqvist C, von Smitten K, Kalso E (1997) Treatment-related factors predisposing to chronic pain in patients with breast cancer—a multivariate approach. Acta Oncol 36(6):625–630CrossRefPubMed

40.

Andersen KG, Jensen MB, Kehlet H, Gartner R, Eckhoff L, Kroman N (2012) Persistent pain, sensory disturbances and functional impairment after adjuvant chemotherapy for breast cancer: cyclophosphamide, epirubicin and fluorouracil compared with docetaxel + epirubicin and cyclophosphamide. Acta Oncol 51(8):1036–1044CrossRefPubMed

41.

Mehnert A, Koch U (2007) Prevalence of acute and post-traumatic stress disorder and comorbid mental disorders in breast cancer patients during primary cancer care: a prospective study. Psychooncology 16(3):181–188CrossRefPubMed

42.

Mulligan EA, Wachen JS, Naik AD, Gosian J, Moye J (2014) Cancer as a criterion a traumatic stressor for veterans: prevalence and correlates. Psychol Trauma-Us 6:S73–S81CrossRef

43.

Widows MR, Jacobsen PB, Fields KK (2000) Relation of psychological vulnerability factors to posttraumatic stress disorder symptomatology in bone marrow transplant recipients. Psychosom Med 62(6):873–882CrossRefPubMed

44.

Green BL, Rowland JH, Krupnick JL, Epstein SA, Stockton P, Stern NM et al (1998) Prevalence of posttraumatic stress disorder in women with breast cancer. Psychosomatics 39(2):102–111CrossRefPubMed

45.

Jacobsen PB, Sadler IJ, Booth-Jones M, Soety E, Weitzner MA, Fields KK (2002) Predictors of posttraumatic stress disorder symptomatology following bone marrow transplantation for cancer. J Consult Clin Psychol 70(1):235–240CrossRefPubMed

46.

Ozkaraman A, Culha I, Fadiloglu ZC, Kosgeroglu N, Gokce S, Alparslan GB (2015) Relationships between social support and social image concerns in Turkish women with breast cancer. Asian Pac J Cancer Prev 16(5):1795–1802CrossRefPubMed

47.

Dedeli OFÇ (2008) Uslu R A survey of functional living and social support in patients with cancer. J Med Oncol 28:132–139

48.

Kinsinger SW, Laurenceau JP, Carver CS, Antoni MH (2011) Perceived partner support and psychosexual adjustment to breast cancer. Psychol Health 26(12):1571–1588CrossRefPubMed

Title: Breast cancer survivors suffer from persistent postmastectomy pain syndrome and posttraumatic stress disorder (ORTHUS study): a study of the palliative care working committee of the Turkish Oncology Group (TOG)
Authors: Ali Alkan
Zeynep Gulsum Guc
Filiz Cay Senler
Tugba Yavuzsen
Handan Onur
Mutlu Dogan
Ebru Karci
Arzu Yasar
Elif Berna Koksoy
Ozgur Tanriverdi
Serdar Turhal
Yuksel Urun
Asiye Ozkan
Dilsa Mizrak
Hakan Akbulut
Publication date: 01-09-2016
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 9/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-016-3202-6

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Method

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2016

Depressive symptoms in older long-term colorectal cancer survivors: a population-based analysis using the SEER-Medicare healthcare outcomes survey

Successful management of chronic disseminated candidiasis in hematologic patients treated with high-dose liposomal amphotericin B: a retrospective study of the SEIFEM registry

“Same-Day” administration of pegfilgrastim following myelosuppressive chemotherapy: clinical practice and provider rationale

Patient-Generated Subjective Global Assessment Short Form (PG-SGA SF) is a valid screening tool in chemotherapy outpatients

Symptom clusters in patients with cancer in the hospice/palliative care setting

Cancer-related fatigue: appraising evidence-based guidelines for screening, assessment and management

Keynote webinar | Spotlight on antibody–drug conjugates in cancer